Zobrazeno 11 - 20
of 205
pro vyhledávání: '"Edward Kerwin"'
Publikováno v:
International Journal of Chronic Obstructive Pulmonary Disease
Gary T Ferguson,1 Edward M Kerwin,2 Tara Rheault,3 Thomas Bengtsson,4 Kathleen Rickard3 1Pulmonary Research Institute of Southeast Michigan, Farmington Hills, MI, USA; 2Altitude Clinical Consulting, Medford, OR, USA; 3Verona Pharma, Plc, Raleigh, NC,
Autor:
Isabel, Leroux-Roels, Matthew G, Davis, Katie, Steenackers, Brandon, Essink, Corinne, Vandermeulen, Charles, Fogarty, Charles P, Andrews, Edward, Kerwin, Marie Pierre, David, Laurence, Fissette, Carline Vanden, Abeele, Delphine, Collete, Magali, de Heusch, Bruno, Salaun, Nathalie, De Schrevel, Juliane, Koch, Céline, Verheust, Nancy, Dezutter, Frank, Struyf, Narcisa, Mesaros, Jelena, Tica, Veronica, Hulstrøm
Publikováno v:
The Journal of infectious diseases.
The aim was to investigate safety and immunogenicity of vaccine formulations against respiratory syncytial virus (RSV) containing the stabilized prefusion conformation of RSV fusion protein (RSVPreF3).This phase I/II, randomized, controlled, observer
Autor:
Dawn Edwards, Edward Kerwin, Louis-Philippe Boulet, Guy Brusselle, Ian D. Pavord, Huib A. M. Kerstjens, Maggie Tabberer, Neal Sule, Robert A. Nathan, Nicola A. Hanania, Neil Barnes, John Oppenheimer, Guy Peachey, Steven Pascoe, Zelie Bailes, Andrew Fowler, Laurie A Lee, Alberto Papi
Publikováno v:
The Lancet. Respiratory Medicine, 9(1), 69-84. ELSEVIER SCI LTD
Background:Despite inhaled corticosteroid plus long-acting β2-agonist (ICS/LABA) therapy, 30–50% of patients with moderate or severe asthma remain inadequately controlled. We investigated the safety and efficacy of single-inhaler fluticasone furoa
Autor:
Stefan Andreas, Marco Testa, Laurent Boyer, Guy Brusselle, Wim Janssens, Edward Kerwin, Alberto Papi, Bonavuth Pek, Luis Puente-Maestu, Dinesh Saralaya, Henrik Watz, Tom M A Wilkinson, Daniela Casula, Gennaro Di Maro, Maria Lattanzi, Luca Moraschini, Sonia Schoonbroodt, Annaelisa Tasciotti, Ashwani K Arora, François Maltais, Jean-Louis Corhay, Eduard Janssens, Mathias Leys, Murdo Ferguson, Mark Fitzgerald, Irvin Mayers, Shelly McNeil, Arnaud Bourdin, Francis Couturaud, Luc Dussart, Gabriele Illies, Andreas Eich, Andrea Ludwig-Sengpiel, Francesco Blasi, Stefano Centanni, Carlo Pomari, José Maria Echave-Sustaeta, Eleuterio Llorca Martínez, Silvia Narejos Pérez, Sergi Pascual-Guardia, Mercè Pérez Vera, Manuel Terns Riera, William Anderson, Gourab Choudhury, Anthony De-Soyza, Tom MA Wilkinson, Joseph Boscia III, Kenneth Chinsky, Leonard Dunn, David Erb, Charles Fogarty, Herman Jackson Downey, Craig Kunz, Terry Poling, Richard Sellman, Barry Sigal, John Southard, Selwyn Spangenthal, Ziad Tannous
Publikováno v:
The Lancet Respiratory Medicine
The Lancet Respiratory Medicine, Elsevier, 2022, ⟨10.1016/S2213-2600(21)00502-6⟩
The Lancet Respiratory Medicine, Elsevier, 2022, ⟨10.1016/S2213-2600(21)00502-6⟩
International audience; BackgroundAcute exacerbations of chronic obstructive pulmonary disease (AECOPD) are associated with changes in the sputum microbiome, including an increased prevalence of pathogenic bacteria. Vaccination against the most frequ
Publikováno v:
Journal of Aerosol Medicine and Pulmonary Drug Delivery
Background: Primatene® MIST CFC, an epinephrine metered-dose inhaler (MDI), was discontinued from the market owing to environmental concerns from its use of chlorofluorocarbon (CFC) propellant. As a result, a new epinephrine MDI was developed using
Autor:
Laurie Lee, Michael E. Manning, Neal Sule, Maggie Tabberer, Ian D. Pavord, David M. Mannino, Andrew Fowler, John Oppenheimer, Nicola A. Hanania, Mark Millard, Robert A. Nathan, Guy Peachey, Edward Kerwin, Huib A. M. Kerstjens, Agne Zarankaite
Publikováno v:
Chest. 158:A35-A38
Autor:
Steven Weinstein, Agne Zarankaite, Robert A. Nathan, Edward Kerwin, Louis-Philippe Boulet, Alberto Papi, Neal Sule, Andrew Fowler, David M. Mannino, Mark C. Liu, Diego Maselli Caceres, Ian D. Pavord, Nicola A. Hanania, John Oppenheimer, Guy Peachey, Laurie Lee, Huib A. M. Kerstjens
Publikováno v:
Chest. 158:A2621-A2625
Autor:
Edward Kerwin, Amanda Caldwell-Tarr, Rebecca M Conto, Carole Dembek, Judith J. Stephenson, Mark Paullin
Publikováno v:
International Journal of Chronic Obstructive Pulmonary Disease. 15:1713-1727
Purpose To assess clinical characteristics and device satisfaction of patients with chronic obstructive pulmonary disease (COPD) treated with glycopyrrolate/eFlow® Closed System (CS) nebulizer (further referred to as eFlow) under real-world conditio
Autor:
Mary Z. Luo, Thomas R Murphy, Edward Kerwin, Jack Yongfeng Zhang, Donald P. Tashkin, George W. Bensch, Tony Marrs
Publikováno v:
Journal of Aerosol Medicine and Pulmonary Drug Delivery
Background: Two sequential single-dose crossover dose-ranging studies were performed to evaluate the clinical efficacy and safety profile of epinephrine hydrofluroalkane (HFA) metered-dose inhaler (MDI) formulation at various doses in subjects with a
Publikováno v:
International Journal of Chronic Obstructive Pulmonary Disease. 15:1225-1243
Analytic epidemiological studies cover a large spectrum of study methodologies, ranging from noninterventional observational studies (population-based, case-control, or cohort studies) to interventional studies (clinical trials). Herein, we review th